Laboratory synthesis replicates that sequence to produce a stable compound for study
7 Recently, a retrospective review of over 16,000 patients presenting to a tertiary neuro-ophthalmology practice showed a potential link between semaglutide and NA-AION
The peptide's dopaminergic effects may interact with these medications
If you take medications for other conditionsincluding diabetes, blood pressure, or mental healthinform your PlexusDx clinician before starting semaglutide so they can screen for problematic interactions
In particular, retatrutide, a triple agonist targeting GLP-1 receptors, GIP, and glucagon receptors, has demonstrated substantial metabolic benefits, raising interest in its potential for treating substance use disorders as well (Jastreboff et al